ANCA-Associated Vasculitis: Practical Issues in Management

被引：2

作者：

Roper, Tayeba ^{[1
]}

Salama, Alan David ^{[1
]}

机构：

[1] Royal Free Hosp, UCL Dept Renal Med, London NW3 2PF, England

来源：

INDIAN JOURNAL OF NEPHROLOGY | 2024年 / 34卷 / 01期

关键词：

Anti neutrophil cytoplasm antibody; glucocorticoids; granulomatosis with polyangiitis; microscopic polyangiitis; pathogenesis; treatment; vasculitis; ANTIBODY-ASSOCIATED VASCULITIS; RHEUMATOLOGY CLASSIFICATION CRITERIA; DAILY ORAL CYCLOPHOSPHAMIDE; 2022; AMERICAN-COLLEGE; SYSTEMIC VASCULITIS; RANDOMIZED-TRIAL; PLASMA-EXCHANGE; WEGENERS-GRANULOMATOSIS; RENAL SURVIVAL; RITUXIMAB;

D O I：

10.4103/ijn.ijn_346_23

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

ANCA associated vasculitides are multi-system autoimmune diseases which are increasing in prevalence. In this review we will discuss the clinical manifestations and review the management options. We highlight the various trials of induction and maintenance therapy and discuss the areas of unmet need. These include understanding which patients are at highest risk of relapse, clinical adaptation of improved biomarkers of disease activity and tools to discuss long term prognosis

引用

页码：6 / 23

页数：18

共 50 条

[41] 2017 Clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of ANCA-associated vasculitis
Harigai, Masayoshi
Nagasaka, Kenji
Amano, Koichi
Bando, Masashi
Dobashi, Hiroaki
Kawakami, Tamihiro
Kishibe, Kan
Murakawa, Yohko
Usui, Joichi
Wada, Takashi
Tanaka, Eiichi
Nango, Eishu
Nakayama, Takeo
Tsutsumino, Michi
Yamagata, Kunihiro
Homma, Sakae
Arimua, Yoshihiro
MODERN RHEUMATOLOGY, 2019, 29 (01) : 20 - 30
[42] ANCA-associated vasculitis
Kitching, A. Richard
Anders, Hans-Joachim
Basu, Neil
Brouwer, Elisabeth
Gordon, Jennifer
Jayne, David R.
Kullman, Joyce
Lyons, Paul A.
Merkel, Peter A.
Savage, Caroline O. S.
Specks, Ulrich
Kain, Renate
NATURE REVIEWS DISEASE PRIMERS, 2020, 6 (01)
[43] Update on Maintenance Therapies for ANCA-Associated Vasculitis
Christian Pagnoux
Aurore Fifi-Mah
Current Treatment Options in Rheumatology, 2021, 7 : 112 - 133
[44] Remission maintenance in ANCA-associated vasculitis: does one size fit all?
Berti, Alvise
Specks, Ulrich
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2019, 15 (12) : 1273 - 1286
[45] ANCA-associated vasculitis-treatment standard
Chalkia, Aglaia
Jayne, David
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 (06) : 944 - 955
[46] Reducing glucocorticoid duration in ANCA-associated vasculitis: A pilot trial
Miloslaysky, Eli M.
Niles, John L.
Wallace, Zachary S.
Cortazar, Frank B.
Fernandes, Ana
Laliberte, Karen
Stone, John H.
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2018, 48 (02) : 288 - 292
[47] Diagnosis and management of ANCA associated vasculitis
Berden, Annelies
Goceroglu, Arda
Jayne, David
Luqmani, Raashid
Rasmussen, Niels
Bruijn, Jan Anthonie
Bajema, Ingeborg
BMJ-BRITISH MEDICAL JOURNAL, 2012, 344
[48] Management and Outcomes of ANCA-Associated Vasculitis at a Tertiary Healthcare Facility
Moollan, Nabeehah
Ahmed, Adeel Rafi
Denton, Mark
AUTOIMMUNE DISEASES, 2022, 2022
[49] ANCA-Associated Renal Vasculitis - An Update
Tesar, Vladimir
Hruskova, Zdenka
NEW INSIGHTS INTO GLOMERULONEPHRITIS: PATHOGENESIS AND TREATMENT, 2013, 181 : 216 - 228
[50] Biological drugs in ANCA-associated vasculitis
Lutalo, Pamela M. K.
D'Cruz, David P.
INTERNATIONAL IMMUNOPHARMACOLOGY, 2015, 27 (02) : 209 - 212

← 1 2 3 4 5 →